Repifermin

DB06434ExperimentalSmall molecule

Investigated for use/treatment in bone marrow transplant, ulcers, and inflammatory bowel disease.

Primary indication
Investigated for use/treatment in bone marrow transplant, ulcers, and inflammatory bowel disease.Curator reviewed

Resolves to

Compound
UNIIPW4W1FNC33CAS219527-63-6

Which companies are running trials of Repifermin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In